Graphene Manufacturing Group Appoints Former Wall Street Veteran and Manufacturing Entrepreneur Jack Perkowski to Its Board of Directors
BRISBANE, AUS, Sep 8, 2023 – (ACN Newswire) – Graphene Manufacturing Group Ltd. (TSXV:GMG) (“GMG”…
News
Graphene Manufacturing Group Appoints Former Wall Street Veteran and Manufacturing Entrepreneur Jack Perkowski to Its Board of Directors
Brisbane, Queensland, Australia–(ACN Newswire – September 8, 2023) – Graphene Manufacturing Group Ltd. (TSXV:GMG) (“GMG”…
Viz.ai to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
SAN FRANCISCO–(BUSINESS WIRE)–#ai–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced…
ISG Women in Digital Award Winners Named for Americas
Leaders with Johnson Controls, Kaiser Permanente, LTIMindtree, McKesson and the National Renewable Energy Laboratory named…
Dodge Momentum Index Drops 6.5% in August
Double-digit dip in institutional planning deflates August reading HAMILTON, N.J.–(BUSINESS WIRE)–The Dodge Momentum Index (DMI),…
Altus Power Adds 3 MW of Solar Assets in the Greater Boston Area
STAMFORD, Conn.–(BUSINESS WIRE)–Altus Power (NYSE: AMPS), the leading commercial-scale provider of clean electric power, today…
Coherus Completes Surface Oncology Acquisition
– Clinical-stage product candidates, casdozokitug and CHS-114, significantly advancenext-generation immuno-oncology portfolio focused on the tumor…
Coherus Completes Surface Oncology Acquisition
– Clinical-stage product candidates, casdozokitug and CHS-114, significantly advancenext-generation immuno-oncology portfolio focused on the tumor…
Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test
New assays for ketamine and tramadol testing pass initial Intelligent Fingerprinting design phase and begin…
Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test
New assays for ketamine and tramadol testing pass initial Intelligent Fingerprinting design phase and begin…
Parion Sciences Announces Publication of Phase 2 CLEAN-PCD Study in The Lancet Respiratory Medicine
Published Phase 2 Study findings demonstrate safety and efficacy of idrevloride in hypertonic saline for…
Parion Sciences Announces Publication of Phase 2 CLEAN-PCD Study in The Lancet Respiratory Medicine
Published Phase 2 Study findings demonstrate safety and efficacy of idrevloride in hypertonic saline for…
CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology
BERKELEY HEIGHTS, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology
BERKELEY HEIGHTS, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquisition Strategy Differentiates Company in Projected $51B Global Cannabis Market
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — via IBN — Lucy Scientific Discovery Inc. (NASDAQ:…
Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquisition Strategy Differentiates Company in Projected $51B Global Cannabis Market
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — via IBN — Lucy Scientific Discovery Inc. (NASDAQ:…
Spectral Medical Featured in New Episode of ‘The Balancing Act’ Airing on Lifetime TV Focused on Endotoxic Septic Shock
Episode to be Broadcast on Monday, September 11th and Tuesday, September 19th 2023 at 7:30…
Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference
WALTHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company…
Rhythm Pharmaceuticals Announces Update to September Conference Participation
BOSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical…
Aditxt, Inc. (NASDAQ: ADTX) Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference September 11th-13th, 2023
Aditxt Chairman, Co-Founder, and Chief Executive Officer Amro Albanna will deliver the company presentation on…